1. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med. 1999; 341:1284–1291. PMID:
10528040.
Article
2. Hisamatsu T, Naganuma M, Matsuoka K, Kanai T. Diagnosis and management of intestinal Behçet's disease. Clin J Gastroenterol. 2014; 7:205–212. PMID:
24883128.
Article
3. Yang SK. Intestinal Behcet's disease. Intest Res. 2005; 3:1–10.
4. Karincaoglu Y, Borlu M, Toker SC, et al. Demographic and clinical properties of juvenile-onset Behçet's disease: a controlled multicenter study. J Am Acad Dermatol. 2008; 58:579–584. PMID:
18045733.
Article
5. Al Mosawi ZS, Madan W, Fareed E. Pediatric-onset Behçet disease in Bahrain: report of nine cases and literature review. Arch Iran Med. 2012; 15:485–487. PMID:
22827784.
6. Tabata M, Tomomasa T, Kaneko H, Morikawa A. Intestinal Behçet's disease: a case report and review of Japanese reports in children. J Pediatr Gastroenterol Nutr. 1999; 29:477–481. PMID:
10512413.
Article
7. André MF, Piette JC, Kémény JL, et al. Aseptic abscesses: a study of 30 patients with or without inflammatory bowel disease and review of the literature. Medicine (Baltimore). 2007; 86:145–161. PMID:
17505254.
8. Quilichini R, Mazzerbo F, Baume D, Carsuzaa F, Burtey S. Sweet's syndrome and aseptic abscess of the spleen. Rev Med Interne. 1996; 17:1029–1031. PMID:
9008752.
9. Klinger S, Mathis N, Jackson S. Bullous Sweet syndrome associated with an aseptic splenic abscess. Cutis. 2009; 84:255–258. PMID:
20099618.
10. Fukuhara K, Urano Y, Kimura S, Hori K, Arase S. Pyoderma gangrenosum with rheumatoid arthritis and pulmonary aseptic abscess responding to treatment with dapsone. Br J Dermatol. 1998; 139:556–558. PMID:
9767321.
Article
11. Johnson JL, West DA, Haggstrom AN. Pyoderma gangrenosum associated with an aseptic splenic abscess in a patient with neurofibromatosis. Pediatr Dermatol. 2015; 32:113–117. PMID:
23535023.
Article
12. Maeshima K, Ishii K, Inoue M, Himeno K, Seike M. Behçet's disease complicated by multiple aseptic abscesses of the liver and spleen. World J Gastroenterol. 2013; 19:3165–3168. PMID:
23717000.
Article
13. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet. 1990; 335:1078–1080. PMID:
1970380.
14. Cheon JH, Kim ES, Shin SJ, et al. Development and validation of novel diagnostic criteria for intestinal Behçet's disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol. 2009; 104:2492–2499. PMID:
19532129.
Article
15. Cheon JH, Shin SJ, Kim SW, et al. Diagnosis of intestinal Behçet's disease. Korean J Gastroenterol. 2009; 53:187–193. PMID:
19835220.
16. Kobayashi K, Ueno F, Bito S, et al. Development of consensus statements for the diagnosis and management of intestinal Behçet's disease using a modified Delphi approach. J Gastroenterol. 2007; 42:737–745. PMID:
17876543.
Article
17. Kinoshita H, Kunisaki R, Yamamoto H, et al. Efficacy of infliximab in patients with intestinal Behçet's disease refractory to conventional medication. Intern Med. 2013; 52:1855–1862. PMID:
23994973.
Article
18. Caporuscio S, Pranteda G, Nistico S, et al. An incomplete form of childhood Behçet's disease treated with infliximab. Int J Immunopathol Pharmacol. 2014; 27:445–448. PMID:
25280037.
Article
19. Cheon JH, Han DS, Park JY, et al. Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet's disease. Inflamm Bowel Dis. 2011; 17:605–613. PMID:
20848515.
Article